Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
15
Drug Approvals
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer
- Conditions
- Prostate CancerProstate AdenocarcinomaBiochemical Recurrence of Malignant Neoplasm of Prostate
- Interventions
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 235
- Registration Number
- NCT06235099
- Locations
- 🇺🇸
Providence Medical Foundation, Fullerton, California, United States
🇺🇸Tower Urology, Los Angeles, California, United States
🇺🇸VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
- Conditions
- Prostate AdenocarcinomaProstate Cancer
- Interventions
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 323
- Registration Number
- NCT06235151
- Locations
- 🇺🇸
Arkansas Urology, Little Rock, Arkansas, United States
🇺🇸Providence Medical Foundation, Fullerton, California, United States
🇺🇸Tower Urology, Los Angeles, California, United States
Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer
- Conditions
- Metastasis From Malignant Tumor of Prostate (Disorder)
- Interventions
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 26
- Registration Number
- NCT05653856
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸Edward Hines, Jr. VA Hospital, Hines, Illinois, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
- Conditions
- Metastasis From Malignant Tumor of Prostate
- Interventions
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 439
- Registration Number
- NCT05204927
- Locations
- 🇺🇸
Arizona Institute of Urology, PPLC, Tucson, Arizona, United States
🇺🇸Providence Medical Foundation, Fullerton, California, United States
🇺🇸Long Beach Memorial Center, Long Beach, California, United States
Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)
- Conditions
- Neuroendocrine Tumors
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Curium US LLC
- Registration Number
- NCT04334837